Evidence density by domain
Click a bar to open the filtered study explorer.
Verified evidence map · 2026-07-28
Autoimmune skin disease trials, organized for rapid clinical reference.
Navigate management-changing studies, exact outcome metrics, routes of administration, emerging programs, negative evidence, safety caveats, and full citations across rheumatologic–dermatologic disease.
Evidence-state mix
Landmark, emerging, negative, comparative, and supportive evidence.
214records
Publication timeline
Study/program year across the curated evidence map.
Navigate by disease domain
Each card summarizes evidence density, direct skin relevance, emerging programs, and critical negative evidence.
Practice-changing study spotlights
Cross-disease anchors selected from the evidence map.
Critical interpretation alerts
Corrections and caveats that materially change how evidence should be used.
Fast search examples
Use natural language or structured field syntax.
Study explorer
Search all 26 study fields, combine filters, bookmark studies, compare up to four records, and export the current result set.
Evidence gaps and priority study designs
Unresolved questions, why they matter, and the experiments most likely to change management.
Endpoint and abbreviation glossary
Search disease abbreviations, outcome measures, treatment classes, and trial terminology used throughout the dashboard.
Methods, provenance, and reconciliation audit
Inclusion standards, quantitative-outcome rules, citation hierarchy, limitations, and source-level corrections.
Downloadable source artifacts
These links work when the dashboard is opened from the extracted package.
Report reconciliation audit
Disposition of supplied studies, source-only materials, outdated statements, and citation corrections.